James B Weissman
CIK 1598480 · Chief Operating Officer & EVP · last filed 2024-07-26
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$1
Companies
2
Total Filings
42
Lifetime Open-Market Net
-$5.81M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| TBIO | Director | 8,390 | $0.00 | $1 | $0 | 1 | 2024-07-26 |
| Dicerna Pharmaceuticals Inc (DRNA) Delisted | Chief Operating Officer & EVP | 0 | $38.22 | $0 | -$5.81M | 41 | 2021-12-29 |
Recent Filings · Page 3 of 5
42 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2020-01-10 | Dicerna Pharmaceuticals Inc (DRNA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-01-03 | Dicerna Pharmaceuticals Inc (DRNA) Delisted | Mixed | — | -$81.8K | EDGAR |
| 2019-12-19 | Dicerna Pharmaceuticals Inc (DRNA) Delisted | Mixed | +7,156 | -$9 | EDGAR |
| 2019-12-03 | Dicerna Pharmaceuticals Inc (DRNA) Delisted | Mixed | — | -$460.6K | EDGAR |
| 2019-11-20 | Dicerna Pharmaceuticals Inc (DRNA) Delisted | Mixed | — | -$783.2K | EDGAR |
| 2019-11-15 | Dicerna Pharmaceuticals Inc (DRNA) Delisted | Mixed | — | -$331.6K | EDGAR |
| 2019-11-01 | Dicerna Pharmaceuticals Inc (DRNA) Delisted | Mixed | — | -$218.7K | EDGAR |
| 2019-10-18 | Dicerna Pharmaceuticals Inc (DRNA) Delisted | Exer (M) | +4,904 | $16.8K | EDGAR |
| 2019-08-23 | Dicerna Pharmaceuticals Inc (DRNA) Delisted | Sell (S) | −14,680 | -$191.8K | EDGAR |
| 2019-04-04 | Dicerna Pharmaceuticals Inc (DRNA) Delisted | Mixed | — | -$173.7K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.